pyrazolo(3,4-d)pyrimidine has been researched along with Thyroid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alì, G; Antonelli, A; Berti, P; Bocci, G; Corti, A; Da Settimo, F; Danesi, R; Fallahi, P; Ferrari, SM; Fioravanti, A; Fontanini, G; La Motta, C; Miccoli, P; Minuto, M; Piaggi, S; Sartini, S | 1 |
1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Thyroid Neoplasms
| Article | Year |
|---|---|
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Capillaries; Carcinoma, Papillary; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; DNA, Neoplasm; Humans; Male; Mice; Mice, Nude; Microdissection; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Thrombospondins; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2011 |